Role for Hypocretin in Mediating Stress-Induced Reinstatement of Cocaine-Seeking Behavior
Hypocretin-1 and -2 (Hcrt-1 and Hcrt-2), also referred to as orexin-A and -B, are neuropeptides synthesized by a few thousand neurons in the lateral hypothalamus. Hypocretin-containing neurons project throughout the brain, with a prominent input to basal forebrain structures involved in motivation,...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 102; no. 52; pp. 19168 - 19173 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
27.12.2005
National Acad Sciences |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Hypocretin-1 and -2 (Hcrt-1 and Hcrt-2), also referred to as orexin-A and -B, are neuropeptides synthesized by a few thousand neurons in the lateral hypothalamus. Hypocretin-containing neurons project throughout the brain, with a prominent input to basal forebrain structures involved in motivation, reward, and stress. However, the role of hypocretins in addiction-related behaviors remains largely unexplored. Here we show that intracerebroventricular infusions of Hcrt-1 lead to a dose-related reinstatement of cocaine seeking without altering cocaine intake in rats. Hcrt-1 also dramatically elevates intracranial self-stimulation thresholds, indicating that, unlike treatments with reinforcing properties such as cocaine, Hcrt-1 negatively regulates the activity of brain reward circuitries. Hypocretin-induced reinstatement of cocaine seeking was prevented by blockade of noradrenergic and corticotropin-releasing factor systems, suggesting that Hcrt-1 reinstated drug seeking through induction of a stress-like state. Consistent with this interpretation, the selective Hcrt-1 receptor antagonist SB-334867 blocked footshock-induced reinstatement of previously extinguished cocaine-seeking behavior. These findings reveal a previously unidentified role for hypocretins in driving drug seeking through activation of stress pathways in the brain. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Author contributions: B.B., A.M., G.F.K., and L.d.L. designed research; B.B., P.J.K., and S.E.S. performed research; R.M.-F. and A.M. contributed new reagents/analytic tools; B.B., P.J.K., G.F.K., and L.d.L. analyzed data; and B.B., P.J.K., G.F.K., and L.d.L. wrote the paper. Edited by James L. McGaugh, University of California, Irvine, CA Abbreviations: CRF, corticotropin-releasing factor; FR1 TOn, fixed ratio 1, timeout n-s; Hcrt, hypocretin; ICSS, intracranial self-stimulation; i.c.v., intracerebroventricular; LH, lateral hypothalamic. Conflict of interest statement: No conflicts declared. Present address: Department of Drug Discovery and Pharmacogenomics, Scripps Florida, 5353 Parkside Drive, RF-2, Jupiter, FL 33458. This paper was submitted directly (Track II) to the PNAS office. To whom correspondence may be addressed at: Center for Psychiatric Neuroscience, 1er étage, CH-1008 Prilly, Switzerland. E-mail: benjamin.boutrel@chuv.ch. **To whom correspondence may be addressed at: Department of Molecular Biology, MB10, The Scripps Research Institute, La Jolla, CA 92037. E-mail: llecea@scripps.edu. |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.0507480102 |